
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Healius Limited is a medical care facilities business based in Australia. Healius shares (HLS) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Healius has a trailing 12-month revenue of around $1.6 billion.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
Since the stock market crash in March caused by coronavirus, Healius's share price has had significant positive movement.
Its last market close was $3.76, which is 22.07% up on its pre-crash value of $2.93 and 91.84% up on the lowest point reached during the March crash when the shares fell as low as $1.96.
If you had bought $1,000 worth of Healius shares at the start of February 2020, those shares would have been worth $770.56 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,287.69.
52-week range | $1.925 - $4.01 |
---|---|
50-day moving average | $3.7768 |
200-day moving average | $3.4501 |
Target price | $2.76 |
PE ratio | 30.5316 |
Dividend yield | $0.06 (1.55%) |
Earnings per share (TTM) | $0.163 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$3.76 on 2020-10-22
1 week (2021-01-07) | -1.05% |
---|---|
1 month (2020-12-17) | -5.53% |
3 months (2020-10-16) | 8.67% |
6 months (2020-07-17) | 23.28% |
1 year (2020-01-17) | 27.89% |
---|---|
2 years (2019-01-17) | 35.25% |
3 years (2018-01-17) | 5.62% |
5 years (2016-01-15) | 51.61% |
Valuing Healius stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Healius's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Healius's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, Healius shares trade at around 31x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Healius's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $137.7 million (£0.0 million).
The EBITDA is a measure of a Healius's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $1.6 billion |
---|---|
Operating margin TTM | 5.02% |
Gross profit TTM | $518.9 million |
Return on assets TTM | 1.27% |
Return on equity TTM | 3.62% |
Profit margin | -4.41% |
Book value | 3.101 |
Market capitalisation | $2.4 billion |
TTM: trailing 12 months
Dividend payout ratio: 32.5% of net profits
Recently Healius has paid out, on average, around 32.5% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.55% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Healius shareholders could enjoy a 1.55% return on their shares, in the form of dividend payments. In Healius's case, that would currently equate to about A$0.06 per share.
While Healius's payout ratio might seem fairly standard, it's worth remembering that Healius may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 26 March 2020 (the "ex-dividend date").
Over the last 12 months, Healius's shares have ranged in value from as little as $1.925 up to $4.01. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Healius's is 0.93. This would suggest that Healius's shares are less volatile than average (for this exchange).
Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia. The company operates through three segments: Pathology, Imaging, and Day Hospitals. It offers diagnostic imaging services, including X-ray, ultrasound, computerized tomography, mammography, magnetic resonance imaging, nuclear medicine, positron emission tomography, and interventional radiology; and private medical laboratory and pathology services. The company also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin, cancer removal, IVF egg collection, and gynaecological surgery services. It operates 2,234 pathology sites; 15 day hospital sites; and 146 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in St Leonards, Australia.
From the best RC plane for beginners to the top model for aerial photography, these are the six best RC planes in Australia right now.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.